News from the BioRN Cluster

Home  >>  News from the BioRN Cluster

Roche: FDA approves Rituxan Hycela for subcutaneous injection in certain blood cancers

On Juni 23, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Roche: FDA approves Rituxan Hycela for subcutaneous injection in certain blood cancers

Treatment can be administered in five to seven minutes, compared to 1.5 hours or more for intravenous Rituxan* Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) approved Rituxan Hycela™ (rituximab and hyaluronidase human) for subcutaneous (under the skin) injection, for the treatment…

PEPperPRINT: 4A Biotech Co., Ltd. and PEPperPRINT sign distribution agreement for China

On Juni 22, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für PEPperPRINT: 4A Biotech Co., Ltd. and PEPperPRINT sign distribution agreement for China

PEPperPRINT has signed a distribution agreement with 4A Biotech Co., Ltd. Under the terms of the agreement 4A Biotech Co., Ltd. has the exclusive marketing and sales rights for PEPperCHIP® Peptide Microarrays and PEPperMAP® Services in China. 4A Biotech Co., Ltd. was founded in 2009 by a group of Chinese…

Heidelberg Pharma: Heidelberg Pharma Signs Exclusive Multi-target Research Agreement with Takeda for the Development of Antibody Targeted Amanitin Conjugates

On Juni 20, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Heidelberg Pharma: Heidelberg Pharma Signs Exclusive Multi-target Research Agreement with Takeda for the Development of Antibody Targeted Amanitin Conjugates

Munich, Germany, 19 June 2017 WILEX AG (ISIN DE000A11QVV0 / WL6 / FSE) today announced that its subsidiary, Heidelberg Pharma GmbH, Ladenburg, Germany, has signed an exclusive multi-target research agreement with Takeda Pharmaceutical Company Limited (TSE: 4502) for the joint development of antibody drug conjugates (ADCs) that use Amanitin as the payload. Under the terms…

AbbVie: AbbVie and Principia Announce Collaboration on Oral Immunoproteasome Inhibitors

On Juni 20, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für AbbVie: AbbVie and Principia Announce Collaboration on Oral Immunoproteasome Inhibitors

NORTH CHICAGO, Ill. and SOUTH SAN FRANCISCO, Calif., June 13, 2017 /PRNewswire/ — AbbVie (NYSE: ABBV), a global biopharmaceutical company, and Principia Biopharma Inc., a private, clinical-stage biopharmaceutical company, announced today that they have entered a collaboration for the development of oral immunoproteasome inhibitors.  The collaboration is aimed at developing first-in-class…

Digital-Gipfel 2017: Rhein-Neckar ist Leuchtturm für intelligente Vernetzung

On Juni 16, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Digital-Gipfel 2017: Rhein-Neckar ist Leuchtturm für intelligente Vernetzung

Am 12. und 13. Juni war die Metropolregion Rhein-Neckar Gastgeber für den ersten Digital-Gipfel der Bundesregierung (vormals IT-Gipfel). Über 1.600 hochrangige Vertreter aus Politik, Wirtschaft, Gewerkschaften, Wissenschaft und Gesellschaft diskutierten an zwei Tagen die Chancen und Herausforderungen der digitalen Transformation. Schwerpunktthemen der über 30 Veranstaltungen in Ludwigshafen und anderen Orten der…

Heidelberg University: Scientists from Heidelberg and Chicago use optogenetics and mathematical modelling to identify a central molecule in cell mechanics

On Juni 16, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Heidelberg University: Scientists from Heidelberg and Chicago use optogenetics and mathematical modelling to identify a central molecule in cell mechanics

Not only muscle cells, but also all other cell types continually generate forces in the human body. An interdisciplinary cooperation of biologists and physicists including Heidelberg researcher Prof. Dr Ulrich Schwarz now succeeded in performing high-resolution measurements of cell forces using light to switch them on and off in a…

EMBL: Open imaging data for biology

On Juni 16, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für EMBL: Open imaging data for biology

The Image Data Resource: prototype of the first open, online repository linking imaging and molecular data A picture may be worth a thousand words, but only if you understand what you are looking at. The life sciences rely increasingly on 2D, 3D and 4D image data, but its staggering heterogeneity…

DKFZ: Mysterious gene transcripts after cancer therapy

On Juni 13, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für DKFZ: Mysterious gene transcripts after cancer therapy

Drugs that are used in cancer therapy to erase epigenetic alterations in cancer cells simultaneously promote the production of countless mysterious gene transcripts, scientists from the German Cancer Research Center (DKFZ) now report in Nature Genetics. The substances activate hidden regulatory elements in DNA. The unusual gene activity has the…

DKFZ: How bile duct cancer develops and how it can be prevented

On Juni 13, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für DKFZ: How bile duct cancer develops and how it can be prevented

What promotes the development of bile duct cancer in the liver? Are these factors different from those that are responsible for the much more common hepatocellular carcinomas? Scientists from the German Cancer Research Center (DKFZ) and from the Technical University of Munich (TUM) have been the first to uncover the…

Heidelberg University: Researchers in Heidelberg develop a novel approach to monitor functional protein complexes

On Juni 9, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Heidelberg University: Researchers in Heidelberg develop a novel approach to monitor functional protein complexes

Picture: Isabel M. Schopp, Heidelberg University Biochemistry Center Confocal microscopy image showing human cells expressing two interacting proteins (green and blue). Split-BioID labels additional proteins belonging to the same complex (red). The composition of specific functional protein complexes in their cellular environment can now be analysed with unprecedented resolution. The…

EMBL: A molecular atlas showing gene expression in all cells in an entire animal

On Juni 9, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für EMBL: A molecular atlas showing gene expression in all cells in an entire animal

EMBL researchers complete a molecular atlas showing gene expression in all cells in an entire animal Gene expression in the nervous system is revealed in this image of a six-day-old Platynereis larva – a computer composite based on images of hundreds of individual specimens (background), each one showing expression of…

Merck and F-star in €1bn deal

On Juni 8, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für Merck and F-star in €1bn deal

German Merck KGaA has secured an option on UK’s F-Star Biotechnology Ltd’s preclinical bispecific PD-L1/LAG checkpoint inhibitor FS118 and four candidates in discovery stage. At ASCO in Chicago, the companies announced the exclusive option agreement, which brings a €115m upfront payment to F-Star’s bank account. If Merck KGaA exercises the…

Springer: Neue Sachbuchreihe ‚WissenKompakt Medizin‘. Kooperation von Springer mit dem Universitätsklinikum und der Medizinischen Fakultät der Universität Heidelberg

On Juni 8, 2017, Posted by , In News, With Kommentare deaktiviert für Springer: Neue Sachbuchreihe ‚WissenKompakt Medizin‘. Kooperation von Springer mit dem Universitätsklinikum und der Medizinischen Fakultät der Universität Heidelberg

Am Standort Heidelberg kooperieren die international tätige Fachverlagsgruppe mit dem Universitätsklinikum und der Medizinischen Fakultät der Universität Heidelberg Heidelberg, 01. Juni 2017 Um einer breiteren Öffentlichkeit aktuelle medizinische Themen informativ und verständlich zugängig zu machen, erscheint im Springer Verlag die neue Sachbuchreihe WissenKompakt Medizin. Die Reihe ist das Ergebnis einer…

BioMed X and Merck launch two new crowdsourcing projects in the fields of cancer research and biologics manufacturing

On Juni 8, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für BioMed X and Merck launch two new crowdsourcing projects in the fields of cancer research and biologics manufacturing

Heidelberg, Germany, June 8, 2017 – BioMed X announces the launch of two new global calls for application together with Merck KGaA in Darmstadt in the fields of RNA splicing in cancer and engineering of high-performance production cell lines. Talented young scientists from the world’s top universities and research institutions…

PEPperPRINT/PROGEN: The German Federal Ministry of Education and Research (BMBF) approved funds to develop novel test for early diagnosis of rheumatoid arthritis

On Juni 8, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für PEPperPRINT/PROGEN: The German Federal Ministry of Education and Research (BMBF) approved funds to develop novel test for early diagnosis of rheumatoid arthritis

Launch of SeroRA® antigen library enables superior RA biomarker screening Heidelberg, June 7, 2017 – German biotech company PEPperPRINT GmbH announced today that it will develop a novel biomarker test for the early and differentiated diagnosis of rheumatoid arthritis (RA) together with PROGEN Biotechnik GmbH. The German Federal Ministry of…

EMBL-EBI: Human Cell Atlas data platform kicks off with support from CZI

On Juni 2, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für EMBL-EBI: Human Cell Atlas data platform kicks off with support from CZI

EMBL-EBI, the Broad Institute and UCSC Genomics Institute will partner in developing a data coordination platform for the Human Cell Atlas, supported by CZI Stockholm, Sweden, 1 June 2017 – The Chan Zuckerberg Initiative (CZI) has announced financial support for the Human Cell Atlas, which is using sequencing technology to…

DKFZ: Blocking cancer-specific mutations in leukemia and brain tumors

On Mai 30, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für DKFZ: Blocking cancer-specific mutations in leukemia and brain tumors

The substitution of a single amino acid in a metabolic enzyme can be the cause of various types of cancer. Scientists from the German Cancer Research Center (DKFZ) and Heidelberg University Hospital, collaborating with Bayer AG, have now been able to develop a candidate for an agent that is intended…

EMBL: James Sharpe appointed Head of EMBL Barcelona

On Mai 29, 2017, Posted by , In Press Releases, With Kommentare deaktiviert für EMBL: James Sharpe appointed Head of EMBL Barcelona

James Sharpe, who invented a 3D imaging technique for looking at tissues and organs, will be the first Head of EMBL’s new Barcelona site James Sharpe, who invented a 3D imaging technique for looking at tissues and organs, will be the first Head of EMBL Barcelona. The new EMBL site…

DKFZ: Macrophages control the development of nerves and blood vessels in the brain

On Mai 29, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für DKFZ: Macrophages control the development of nerves and blood vessels in the brain

Nerve cells and blood vessels have striking common features during their development. Scientists from the German Cancer Research Center (DKFZ) have shown that macrophages control the growth and branching of nerves as well as blood vessels in the brain. A molecule called CD95 plays a key role in this process….

Apogenix receives PRIME-Status from EMA for the treatment of glioblastoma with Asunercept.

On Mai 29, 2017, Posted by , In Allgemein, With Kommentare deaktiviert für Apogenix receives PRIME-Status from EMA for the treatment of glioblastoma with Asunercept.

Apogenix erhält PRIME-Status von der EMA für Asunercept zur Behandlung des Glioblastoms Das PRIME-Programm wurde entwickelt, damit Patienten so früh wie möglich von stark Lebensqualität verbessernden Therapien profitieren können Heidelberg, Deutschland, 29. Mai 2017 – Das auf Immunonkologie spezialisierte biopharmazeutische Unternehmen Apogenix AG gab heute bekannt, dass es von der…